Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

To Decrease Fatigue With Light Therapy

NCT03242902

Conditions
Diffuse Large B Cell Lymphoma, Dyssomnias, Hemic and Lymphatic Diseases, +17 more
Locations
  • Radboudumc Nijmegen, Gelderland, Netherlands
  • Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
  • VUmc Amsterdam, North Holland, Netherlands
  • Leids Universitair Medisch Centrum Leiden, South Holland, Netherlands
View Trial Details
Completed

Zevalin-beam for Aggressive Lymphoma

NCT00491491

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

NCT02343536

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Safety of Simvastatin in LAM and TSC

NCT02061397

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of LY2835219 in Japanese Participants With Advanced Cancer

NCT02014129

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Tokyo, Japan
View Trial Details

Related conditions